Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 426-428

  Fothergill, Joanne L ^a,b   Mowat, Eilidh ^b   Walshaw, Martin J ^c   Ledson, Martin J ^c   James, Chloe E ^b   Winstanley, Craig ^a,b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; MEROPENEM; NORFLOXACIN; TOBRAMYCIN;

ADULT; ARTICLE; BACTERIUM ISOLATE; CYSTIC FIBROSIS; DRUG EFFECT; HUMAN; LUNG CYSTIC FIBROSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGE; SPUTUM ANALYSIS;

BACTERIOPHAGES; CYSTIC FIBROSIS; HUMANS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA;

EID: 78650660379     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01257-10     Document Type: Article

References (14)

1. Andrews, J. M. 2009. BSAC standardized disc susceptibility testing method (version 8). J. Antimicrob. Chemother. 64:454-489.
2. Blahová, J., M. Hupkova, and V. Krcmery, Sr. 1994. Phage F-116 transduction of antibiotic resistance from a clinical isolate of Pseudomonas aeruginosa. J. Chemother. 6:184-188.
3. Brazas, M. D., and R. E. Hancock. 2005. Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:3222-3227.
4. Brockhurst, M. A., A. Buckling, and P. B. Rainey. 2005. The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, Pseudomonas aeruginosa. Proc. Biol. Sci. 272:1385-1391.
5. Brüssow, H., C. Canchaya, and W. D. Hardt. 2004. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol. Mol. Biol. Rev. 68:560-602.
6. Carter, M. E., J. L. Fothergill, M. J. Walshaw, K. Rajakumar, A. Kadioglu, and C. Winstanley. 2010. A subtype of a Pseudomonas aeruginosa cystic fibrosis epidemic strain exhibits enhanced virulence in a murine model of acute respiratory infection. J. Infect. Dis. 202:935-942.
7. David, H. L., N. Rastogi, S. Clavel-Sérès, and F. Clément. 1986. Action of colistin (polymyxin E) on the lytic cycle of the mycobacteriophage D29 in Mycobacterium tuberculosis. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 262: 321-334.
8. Fothergill, J. L., E. Mowat, M. J. Ledson, M. J. Walshaw, and C. Winstanley. 2010. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. J. Med. Microbiol. 59:472-481.
9. Goerke, C., S. Matias y Papenberg, S. Dasbach, K. Dietz, R. Ziebach, B. C. Kahl, and C. Wolz. 2004. Increased frequency of genomic alterations in Staphylococcus aureus during chronic infection is in part due to phage mobilization. J. Infect. Dis. 189:724-734.
10. McGannon, C. M., C. A. Fuller, and A. A. Weiss. 2010. Different classes of antibiotics differentially influence Shiga toxin production. Antimicrob. Agents Chemother. 54:3790-3798.
11. McGrath, L. T., P. Mallon, L. Dowey, B. Silke, E. McClean, M. McDonnell, A. Devine, S. Copeland, and S. Elborn. 1999. Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax 54:518-523.
12. Scott, F. W., and T. L. Pitt. 2004. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J. Med. Microbiol. 53:609-615.
13. Webb, J. S., M. Lau, and S. Kjelleberg. 2004. Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. J. Bacteriol. 186: 8066-8073.
14. Winstanley, C., M. G. Langille, J. L. Fothergill, I. Kukavica-Ibrulj, C. Paradis-Bleau, F. Sanschagrin, N. R. Thomson, G. L. Winsor, M. A. Quail, N. Lennard, A. Bignell, L. Clarke, K. Seeger, D. Saunders, D. Harris, J. Parkhill, R. E. Hancock, F. S. Brinkman, and R. C. Levesque. 2009. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res. 19:12-23.